Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL
Open Access
- 1 November 1997
- journal article
- Published by Elsevier
- Vol. 8 (11) , 1145-1150
- https://doi.org/10.1023/a:1008215720081
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- In vitro schedule-dependent interaction between paclitaxel and cisplatin in human carcinoma cell linesCancer Chemotherapy and Pharmacology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivoInternational Journal of Cancer, 1995
- Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repairBritish Journal of Cancer, 1995
- Paclitaxel (TaxolTM) and docetaxel (TaxotereTM): Not simply two of a kindAnnals of Oncology, 1994
- Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitroBritish Journal of Cancer, 1994
- Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristineZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.Journal of Clinical Oncology, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976